Commentary: Antibiotic stewardship in pediatrics: A necessity

Pediatric Infectious Disease Journal

Volumn 26, Issue 6, 2007, Pages 538-539

  Bradley, John S ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Children's Specialists of San Diego   (United States)

Author keywords

Antimicrobial resistance; Antimicrobial stewardship; Decision support techniques; Pediatrics

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; CHILD CARE; DRUG CONTROL; DRUG FORMULARY; DRUG PROGRAM; HEALTH CARE POLICY; NOTE; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; BACTERIAL INFECTION; BACTERIUM; DRUG EFFECT; DRUG UTILIZATION; HUMAN; PEDIATRICS; POLICY;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; DRUG RESISTANCE, BACTERIAL; DRUG UTILIZATION; HEALTH POLICY; HUMANS; ORGANIZATIONAL POLICY; PEDIATRICS;

EID: 34249789274     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/INF.0b013e3180593184     Document Type: Review

References (11)

1. Infectious Diseases Society of America. Bad Bugs, No Drugs As Antibiotic R&D Stagnates, a Public Health Crisis Brews. Alexandria, VA: Infectious Diseases Society of America; 2004.
2. Talbot GH, Bradley J, Edwards JE, Gilbert D, Scheld M, Bartlett JG. Bad bugs need drugs: an update on the development pipeline from the antimicrobial availability task force of the Infectious Diseases Society of America. Clin Infect Dis. 2006;42:657-658.
3. Bradley JS, Guidos R, Baragona S, et al. Anti-infective research and development - problems, challenges, and solutions. Lancet Infect Dis. 2007;7:68-78.
4. Dellit TH, Owens RC, McGowan JE Jr, et al. Infectious Diseases Society of America; Society for Healthcare Epidemiology of America. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44:159-77.
5. Goossens H, Ferech M, Vander Stichele R, Elseviers M; ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005;365:579-587.
6. Chen DK, McGeer A, de Azavedo JC, Low DE. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. N Engl J Med. 1999;341:233-239.
7. Nilsson P, Laurell MH. A 10-year follow-up study of penicillin- nonsusceptible S. pneumoniae during an intervention programme in Malmo, Sweden. Scand J Infect Dis. 2006;38:838-844.
8. Yagupsky P. Selection of antibiotic-resistant pathogens in the community. Pediatr Infect Dis J. 2006;25:974-976.
9. Roghmann MC, McGrail L. Novel ways of preventing antibiotic-resistant infections: what might the future hold. Am J Infect Control. 2006;34:469-475.
10. Fishman N. Antimicrobial stewardship. Am J Med. 2006;119(6 suppl 1):S53-S61.
11. Centers for Disease Control and Prevention. Campaign to Prevent Antimicrobial Resistance in Health Care Settings. September 15, 2005. Available at: http://www.cdc.gov/drugresistance/healthcare/default.htm. Accessed January 30, 2007.